STAT+: BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDA
ASCO, Day 2: promising news around lung cancer, new immunotherapies, and bold words from Rick Pazdur.
Read full article →Healthcare Policy
Latest Healthcare Policy news from across the web.
STAT+: China competition, ‘destruction’ at FDA give agency chance to restructure, Rick Pazdur says
Rick Pazdur on the FDA: “We've had a lot of destruction here, and it doesn't mean that we have to just go back and say, well, let's rebuild it as…
Read full article →STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug
CEO Mark Goldsmith says Revolution Medicines will submit pancreatic cancer drug daraxonrasib for FDA approval soon.
Read full article →STAT+: As Ebola outbreak grows, Trump administration veers from previous government playbook
Trump officials are disregarding the Biden administration's detailed pandemic plans in favor of their own strategy.
Read full article →